Publications by authors named "Donald Tindall"

Claim this Profile
A
Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.
Jennifer G Le-Rademacher, Kendrith Rowland, Pamela J Atherton, Christopher Dakhil, Zhifu Sun, Donald Tindall

Am J Hosp Palliat Care· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer.
Yundong He, Ji Lu, Zhenqing Ye, Siyuan Hao, Liewei Wang, Donald J Tindall

Nucleic Acids Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.
Jason W D Hearn, Ghada AbuAli, Chad A Reichard, Chandana A Reddy, Cristina Magi-Galluzzi, Donald Tindall

Lancet Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.
Yu Zhao, Liguo Wang, Shancheng Ren, Lan Wang, Patrick R Blackburn, Donald J Tindall

Cell Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.
Daniel E Spratt, Michael J Evans, Brian J Davis, Michael G Doran, Man Xia Lee, Donald J Tindall

Cancer Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.
Manish Kohli, Charles Yf Young, Donald J Tindall, Debashis Nandy, Kyle M McKenzie

Onco Targets Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are androgen receptor variants a substitute for the full-length receptor?
Ji Lu, Travis Van der Steen, Donald J Tindall

Nat Rev Urol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.
Yu Zhao, Donald J Tindall, Haojie Huang

Int J Biol Sci· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.
Ji Lu, Peter E Lonergan, Lucas P Nacusi, Liguo Wang, Lucy J Schmidt, Donald J Tindall

J Urol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to manuscript by Prof. Donald S. Coffey.
Donald J Tindall

Asian J Urol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and analysis of Gleason score 8-10 prostate cancers in the REDUCE study.
Gerald L Andriole, David G Bostwick, Leonard G Gomella, Michael Marberger, Francesco Montorsi, Donald J Tindall

Urology· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the supercritical extract of azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth.
Qiang Wu, Manish Kohli, H Robert Bergen, John C Cheville, R Jeffrey Karnes, Donald J Tindall

Mol Cancer Ther· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy.
Liya Ding, Shuai Chen, Ping Liu, Yunqian Pan, Jian Zhong, Donald J Tindall

Cancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.
Jian Zhong, Liya Ding, Laura R Bohrer, Yunqian Pan, Ping Liu, Donald J Tindall

Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms.
Diping Wang, Ji Lu, Donald J Tindall

Cancer Lett· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttranslational modification of the androgen receptor in prostate cancer.
Travis van der Steen, Donald J Tindall, Haojie Huang

Int J Mol Sci· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor: past, present and future.
Lucy J Schmidt, Donald J Tindall

Curr Drug Targets· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.
Marissa J Stanton, Samikshan Dutta, Heyu Zhang, Navatha S Polavaram, Alexey A Leontovich, Donald J Tindall

Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells.
Turid Eide, Håkon Ramberg, Carlotta Glackin, Donald Tindall, Kristin Austlid Taskén

Cancer Cell Int· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenic Effects and Therapeutic Targets of Azadirachta indica Leaf Extract in Endothelial Cells.
Saswati Mahapatra, Charles Y F Young, Manish Kohli, R Jeffrey Karnes, Eric W Klee, Donald J Tindall

Evid Based Complement Alternat Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Lucy J Schmidt, Kelly Duncan, Neelu Yadav, Kevin M Regan, Alissa R Verone, Donald J Tindall

Mol Endocrinol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global methylation profiling for risk prediction of prostate cancer.
Saswati Mahapatra, Eric W Klee, Charles Y F Young, Zhifu Sun, Rafael E Jimenez, Donald J Tindall

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydrotestosterone synthesis from adrenal precursors does not involve testosterone in castration-resistant prostate cancer.
Tessa J Campbell, Donald J Tindall, William D Figg

Cancer Biol Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor signaling in prostate cancer development and progression.
Peter E Lonergan, Donald J Tindall

J Carcinog· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically.
Charles J Ryan, Donald J Tindall

J Clin Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis